Cargando…
Rare disease patients in India are rarely involved in international orphan drug trials
We wished to determine whether rare diseases patients from India had been enrolled in international trials to develop novel orphan drugs. There are two reasons to be interested in this. (a) Different ethnic or racial groups may respond differently to a particular drug. India has huge ethnic diversit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021652/ https://www.ncbi.nlm.nih.gov/pubmed/36962798 http://dx.doi.org/10.1371/journal.pgph.0000890 |